Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Observed in pilot human work A 2025 IV infusion pilot of BPC-157 in two adults at 10 mg and 20 mg reported no adverse effects on cardiac, hepatic, renal, thyroid, or glucose biomarkers (Lee et al., Alternative Therapies in Health and Medicine, 2025)
Consult a qualified clinician for medical questions
According to NICE Clinical Knowledge Summary guidance, patients with neurological involvement should receive more intensive initial treatment to optimise recovery potential
Heres where clients in Lutz feel the difference most: Energy & fatigue The headline benefit
In the published literature, BPC-157 is most closely associated with localised tissue repair
US$ 26.70
US$ 26.48
US$ 26.05
US$ 20.80
US$ 24.77
US$ 29.67
US$ 29.47
